头颈部鳞状细胞癌治疗后FDG-PET/CT颈部影像报告和数据系统3类和4类的阳性预测值
回顾性纳入2006至2018年根治性治疗的头颈部鳞状细胞癌患者,评估治疗后PET/CT颈部影像报告和数据系统(NI-RADS)3类和4类的阳性预测值。NI-RADS 3类总体阳性预测值为56%(95%CI 48%-65%),各亚部位为原发灶56%、区域淋巴结65%、远处79%;NI-RADS 4类阳性预测值为100%(95%CI 96%-100%)。作者认为NI-RADS 3类阳性预测值相对较低,建议在启动新挽救治疗方案前进行组织采样确认,以避免不必要的过度治疗及相关毒性;NI-RADS 4类可靠提示复发。
要点
- NI-RADS 3类总体阳性预测值56%(95%CI 48%-65%),原发灶56%、区域淋巴结65%、远处79%。
- NI-RADS 4类全部为真性治疗失败,总体阳性预测值100%(95%CI 96%-100%)。
- 作者建议NI-RADS 3类所见在启动新挽救治疗前应经组织采样确认。
核心结论
- 治疗后PET/CT的NI-RADS 3类阳性预测值相对较低,NI-RADS 4类可靠提示复发。
研究设计与样本
- 回顾性研究,纳入2006至2018年根治性治疗的头颈部鳞状细胞癌患者,治疗后PET/CT在原发灶、区域淋巴结或远处判读为NI-RADS 3类或4类者入选,参考标准为组织病理学或明确的影像学或临床治疗失败证据。
诊断标准与关键数值
- NI-RADS 3类总体阳性预测值56%(95%CI 48%-65%),原发灶56%(44/79)、区域淋巴结65%(34/52)、远处79%(42/53);NI-RADS 4类总体阳性预测值100%(95%CI 96%-100%),原发灶100%(28/28)、区域淋巴结100%(32/32)、远处100%(29/29)。
临床应用与阅片要点
- 作者认为NI-RADS 3类所见应在启动新挽救治疗方案前经组织采样确认,以避免不必要的过度治疗及相关毒性;NI-RADS 4类可靠提示复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: The Neck Imaging Reporting and Data System is a standardized reporting system intended to risk stratify patients treated for head and neck squamous cell carcinoma. The purpose of this study is to investigate the positive predictive value of the Neck Imaging Reporting and Data System categories 3 and 4 on posttreatment PET/CT in patients treated definitively for head and neck squamous cell carcinoma.
MATERIALS AND METHODS: We retrospectively identified patients treated definitively for head and neck squamous cell carcinoma between 2006 and 2018. Patients whose posttreatment PET/CT scans were interpreted as Neck Imaging Reporting and Data System 3 (suspicious) or 4 (definitive recurrence) at the primary site, regional nodes, or at distant sites were included. The reference standard was histopathology or unequivocal imaging or clinical evidence of treatment failure. The positive predictive values of Neck Imaging Reporting and Data System 3 and 4 posttreatment PET/CT were calculated.
RESULTS: Seventy-two of 128 patients with posttreatment PET/CT interpreted as Neck Imaging Reporting and Data System 3 at the primary site, regional nodes, or distant sites were proved to have treatment failure at the suspicious sites, yielding an overall positive predictive value of 56% (95% CI, 48%-65%). The positive predictive values of Neck Imaging Reporting and Data System 3 by subsite were as follows: primary site, 56% (44/79); regional nodes, 65% (34/52); and distant sites, 79% (42/53). All 69 patients with posttreatment PET/CT interpreted as Neck Imaging Reporting and Data System 4 had true treatment failure, yielding a positive predictive value of 100% (95% CI, 96%-100%): primary site, 100% (28/28); regional nodes, 100% (32/32); and distant sites, 100% (29/29).
CONCLUSIONS: The positive predictive value of Neck Imaging Reporting and Data System 3 on posttreatment PET/CT is relatively low. Thus, Neck Imaging Reporting and Data System 3 findings should be confirmed with tissue sampling before instituting new salvage treatment regimens to avoid unnecessary overtreatment and its associated toxicities. Neck Imaging Reporting and Data System 4 reliably indicates recurrent disease.
引用
- Wangaryattawanich P, Branstetter BF, Ly JD, et al. Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma. AJNR Am J Neuroradiol. 2020. PMID: 32467187. doi:10.3174/ajnr.A6589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。